For an extensive period, CD BioGlyco has been committed to advancing the field of Glycosylation Inhibitor Development, placing special emphasis on delivering exceptional services in the realm of Glycosaminoglycan Inhibitor Development. At CD BioGlyco, our heparin inhibitor development services include but are not limited to the following directions.
Fig.1 Process of heparin inhibitor development. (CD BioGlyco)
Fig.2 Schematic illustration of heparin derivatives and applications. (Banik, et al., 2021)
CD BioGlyco uses advanced technical tools and efficient experimental methods to provide one-stop heparin inhibitor development services. We offer a variety of strategies, including techniques such as fluorescence or mass spectrometry, to validate the action and selectivity of potential inhibitors against heparin. Please feel free to contact us for more information.